TENET HEALTHCARE CORP (THC) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:THC • US88033G4073

189.49 USD
-0.09 (-0.05%)
At close: Jan 29, 2026
189.49 USD
0 (0%)
After Hours: 1/29/2026, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to THC. THC was compared to 103 industry peers in the Health Care Providers & Services industry. THC scores excellent on profitability, but there are some minor concerns on its financial health. THC may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make THC suitable for value investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year THC was profitable.
  • THC had a positive operating cash flow in the past year.
  • In the past 5 years THC has always been profitable.
  • THC had a positive operating cash flow in each of the past 5 years.
THC Yearly Net Income VS EBIT VS OCF VS FCFTHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

  • THC's Return On Assets of 4.60% is fine compared to the rest of the industry. THC outperforms 74.76% of its industry peers.
  • THC has a Return On Equity of 33.73%. This is amongst the best in the industry. THC outperforms 94.17% of its industry peers.
  • THC's Return On Invested Capital of 11.65% is amongst the best of the industry. THC outperforms 85.44% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for THC is in line with the industry average of 9.16%.
  • The 3 year average ROIC (9.25%) for THC is below the current ROIC(11.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.6%
ROE 33.73%
ROIC 11.65%
ROA(3y)4.91%
ROA(5y)3.9%
ROE(3y)50.24%
ROE(5y)332.92%
ROIC(3y)9.25%
ROIC(5y)8.01%
THC Yearly ROA, ROE, ROICTHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • THC has a Profit Margin of 6.49%. This is amongst the best in the industry. THC outperforms 84.47% of its industry peers.
  • THC's Profit Margin has improved in the last couple of years.
  • THC has a better Operating Margin (17.52%) than 96.12% of its industry peers.
  • THC's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 82.26%, THC belongs to the best of the industry, outperforming 96.12% of the companies in the same industry.
  • In the last couple of years the Gross Margin of THC has remained more or less at the same level.
Industry RankSector Rank
OM 17.52%
PM (TTM) 6.49%
GM 82.26%
OM growth 3Y10.99%
OM growth 5Y11.36%
PM growth 3Y48.9%
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.27%
THC Yearly Profit, Operating, Gross MarginsTHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), THC is creating some value.
  • The number of shares outstanding for THC has been reduced compared to 1 year ago.
  • THC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for THC has been reduced compared to a year ago.
THC Yearly Shares OutstandingTHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
THC Yearly Total Debt VS Total AssetsTHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • An Altman-Z score of 1.84 indicates that THC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • THC has a Altman-Z score (1.84) which is in line with its industry peers.
  • The Debt to FCF ratio of THC is 8.78, which is on the high side as it means it would take THC, 8.78 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of THC (8.78) is comparable to the rest of the industry.
  • THC has a Debt/Equity ratio of 3.26. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of THC (3.26) is worse than 74.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.26
Debt/FCF 8.78
Altman-Z 1.84
ROIC/WACC1.34
WACC8.67%
THC Yearly LT Debt VS Equity VS FCFTHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

  • THC has a Current Ratio of 1.71. This is a normal value and indicates that THC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.71, THC is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
  • A Quick Ratio of 1.64 indicates that THC should not have too much problems paying its short term obligations.
  • THC has a better Quick ratio (1.64) than 66.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.64
THC Yearly Current Assets VS Current LiabilitesTHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.32% over the past year.
  • Measured over the past years, THC shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.84% on average per year.
  • The Revenue has decreased by -0.56% in the past year.
  • The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)39.32%
EPS 3Y16.22%
EPS 5Y34.84%
EPS Q2Q%26.28%
Revenue 1Y (TTM)-0.56%
Revenue growth 3Y1.98%
Revenue growth 5Y2.26%
Sales Q2Q%3.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.65% on average over the next years. This is quite good.
  • THC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.27% yearly.
EPS Next Y36.74%
EPS Next 2Y17.92%
EPS Next 3Y15.45%
EPS Next 5Y13.65%
Revenue Next Year2.31%
Revenue Next 2Y3.3%
Revenue Next 3Y3.83%
Revenue Next 5Y3.27%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
THC Yearly Revenue VS EstimatesTHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
THC Yearly EPS VS EstimatesTHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

9

4. Valuation

4.1 Price/Earnings Ratio

  • THC is valuated correctly with a Price/Earnings ratio of 12.21.
  • Based on the Price/Earnings ratio, THC is valued cheaper than 83.50% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of THC to the average of the S&P500 Index (28.39), we can say THC is valued rather cheaply.
  • THC is valuated reasonably with a Price/Forward Earnings ratio of 11.45.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of THC indicates a rather cheap valuation: THC is cheaper than 85.44% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of THC to the average of the S&P500 Index (25.72), we can say THC is valued rather cheaply.
Industry RankSector Rank
PE 12.21
Fwd PE 11.45
THC Price Earnings VS Forward Price EarningsTHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, THC is valued cheaper than 90.29% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of THC indicates a rather cheap valuation: THC is cheaper than 82.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.09
EV/EBITDA 6
THC Per share dataTHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • THC has an outstanding profitability rating, which may justify a higher PE ratio.
  • THC's earnings are expected to grow with 15.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y15.45%

0

5. Dividend

5.1 Amount

  • THC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TENET HEALTHCARE CORP / THC FAQ

What is the ChartMill fundamental rating of TENET HEALTHCARE CORP (THC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to THC.


What is the valuation status for THC stock?

ChartMill assigns a valuation rating of 9 / 10 to TENET HEALTHCARE CORP (THC). This can be considered as Undervalued.


Can you provide the profitability details for TENET HEALTHCARE CORP?

TENET HEALTHCARE CORP (THC) has a profitability rating of 9 / 10.


What is the valuation of TENET HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TENET HEALTHCARE CORP (THC) is 12.21 and the Price/Book (PB) ratio is 4.15.


Can you provide the expected EPS growth for THC stock?

The Earnings per Share (EPS) of TENET HEALTHCARE CORP (THC) is expected to grow by 36.74% in the next year.